Clin Exp Otorhinolaryngol.  2012 Sep;5(3):173-176. 10.3342/ceo.2012.5.3.173.

Nasal Hemangiopericytoma Causing Oncogenic Osteomalacia

• Cho SI
• Do NY
• Yu SW
• Choi JY

• KMID: 2134602
• DOI: http://doi.org/10.3342/ceo.2012.5.3.173

Abstract

Oncogenic osteomalacia is a rare cause that makes abnormalities of bone metabolism. Our case arose in a 47-year-old woman presenting a nasal mass associated with osteomalacia. We excised the mass carefully. After surgery, it was diagnosed as hemangiopericytoma and her symptoms related with osteomalacia were relieved and biochemical abnormalities were restored to normal range. We report and review a rare case of nasal hemangiopericytoma that caused osteomalacia.

Keyword

Nasal hemangiopericytoma; Osteomalacia

MeSH Terms

Female
Hemangiopericytoma
Humans
Middle Aged
Neoplasms, Connective Tissue
Osteomalacia
Reference Values
Neoplasms, Connective Tissue

Figure

• 

  Fig. 1 Endoscopic finding showed a smooth pinkish hard mass filling the left nasal cavity.

• 

  Fig. 2 Preoperative contrast-enhanced coronal (A) and axial (B) computed tomography scan revealed a expansile hypervascular tumor in the left nasal cavity and post ethmoid sinus that demonstrated a scattered calcification and expansive bony destruction.

• 

  Fig. 3 (A) Histologic findings of the tumor. Microscopically, this tumor is composed of mainly spindle cells, abundunt blood vessels and metaplastic bony tissues. Spindle cells are interspersed between blood vessels. (B) In immunohistochemical studies, endothelial cells of blood vessels have immunoreactivity for CD34.

Reference

1. Nelson AE, Robinson BG, Mason RS. Oncogenic osteomalacia: is there a new phosphate regulating hormone? Clin Endocrinol (Oxf). 1997; 12. 47(6):635–642. PMID: 9497867.

2. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003; 4. 348(17):1656–1663. PMID: 12711740.

3. Kawai Y, Morimoto S, Sakaguchi K, Yoshino H, Yotsui T, Hirota S, et al. Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excretion of cAMP. J Bone Miner Metab. 2001; 19(1):61–64. PMID: 11156476.

4. Fuentealba C, Pinto D, Ballesteros F, Pacheco D, Boettiger O, Soto N, et al. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma. J Clin Rheumatol. 2003; 12. 9(6):373–379. PMID: 17043447.

5. Inokuchi G, Tanimoto H, Ishida H, Sugimoto T, Yamauchi M, Miyauchi A, et al. A paranasal tumor associated with tumor-induced osteomalacia. Laryngoscope. 2006; 10. 116(10):1930–1933. PMID: 17003734.

6. Beech TJ, Rokade A, Gittoes N, Johnson AP. A haemangiopericytoma of the ethmoid sinus causing oncogenic osteomalacia: a case report and review of the literature. Int J Oral Maxillofac Surg. 2007; 10. 36(10):956–958. PMID: 17498926.

7. Kenealy H, Holdaway I, Grey A. Occult nasal sinus tumours causing oncogenic osteomalacia. Eur J Intern Med. 2008; 11. 19(7):516–519. PMID: 19013380.

8. Gonzalez-Compta X, Manos-Pujol M, Foglia-Fernandez M, Peral E, Condom E, Claveguera T, et al. Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol. 1998; 4. 112(4):389–392. PMID: 9659507.

9. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A. 2001; 5. 98(11):6500–6505. PMID: 11344269.

10. Wilkins GE, Granleese S, Hegele RG, Holden J, Anderson DW, Bondy GP. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab. 1995; 5. 80(5):1628–1634. PMID: 7745010.

11. Furco A, Roger M, Mouchet B, Richard O, Martinache X, Fur A. Osteomalacia cured by surgery. Eur J Intern Med. 2002; 2. 13(1):67–69. PMID: 11836086.

12. Catalano PJ, Brandwein M, Shah DK, Urken ML, Lawson W, Biller HF. Sinonasal hemangiopericytomas: a clinicopathologic and immunohistochemical study of seven cases. Head Neck. 1996; Jan-Feb. 18(1):42–53. PMID: 8774921.